Focused and accessible - a renewed EuroIntervention!

We hope your year has begun well and full of excitement! It certainly has for us at EuroIntervention where we’re still at the beginning of all the new graphic changes and scheduling we spoke about in the last issue. And here it is – the first of our new, leaner, and more timely Journals that you will be receiving every 2 weeks. What do you think? We’re interested in your reactions and comments, so don’t hesitate to contact us online.

And, as for this issue itself, here are the key topics you’ll find right now:

EuroIntervention state-of-the-art

In a state-of-the-art on coronary spasm and vasomotor dysfunction, Zachary S. Yaker, Claire E. Raphael and colleagues review the current understanding, pathophysiology and treatment approaches for this frequently underdiagnosed condition.

Transcatheter aortic valve replacement explant for failed balloon-expandable valves vs failed self-expanding valves

Is mortality in transcatheter aortic valve replacement (TAVR) explantation associated with the type of failed transcatheter heart valve? Syed Zaid, Gilbert H.L. Tang and colleagues compare the outcomes of balloon-expandable valves versus self-expanding valves TAVR explantation using the EXPLANT-TAVR registry. The authors evaluate endocarditis, paravalvular leakage, structural valve deterioration and patient-prosthesis mismatch as well as mortality associated with the explantation of each valve type.

Prolonged mechanical circulatory support in high-risk PCI

What happens when you put high-risk PCI patients on prolonged mechanical circulatory support? Sugi Min, Jeffrey W. Moses and colleagues discuss early recognition of high-risk PCI and how best to wean patients off mechanical circulatory support, including the use of right heart catheterisation.

Real-world management of aortic stenosis patients

In a unique study out of Denmark, Xi Wang, Ole De Backer and colleagues examine the confluence of guideline recommendations and Heart Team evaluations. Focusing on a region with nearly 3 million people where all aortic stenosis patients are channelled through one centre, the authors analyse the value of the Heart Team in this “real-world” practice setting.

Volume 20 Number 2
Jan 15, 2024
Volume 20 Number 2
View full issue

On the same subject

EAPCI Column

Mar 4, 2024
Focus on EAPCI joint sessions


10.4244/EIJ-E-24-00002 Mar 4, 2024
Catheter-based versus surgical mitral valve intervention: choosing between the red pill and the blue pill
Bagur R and McInerney A


10.4244/EIJ-E-23-00068 Mar 4, 2024
Acute changes in microvascular resistance after treating aortic stenosis
Johnson N and Eerdekens R


10.4244/EIJ-E-24-00001 Mar 4, 2024
Navigating the complexities of antithrombotic therapy after LAAO
Alkhouli M


10.4244/EIJ-E-24-00004 Mar 4, 2024
Prophylactic stenting of vulnerable plaques: pros and cons
Park D et al

Original Research

10.4244/EIJ-D-23-00684 Mar 4, 2024
Single antiplatelet therapy following Amplatzer left atrial appendage occlusion
Kramer A et al
Trending articles

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al


10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al


10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved